In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

THOUSAND OAKS, Calif., Oct. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the third quarter of 2024.

It’s worth highlighting that both Keytruda and Welireg are already ... EXEL to seek NET marketing authorization from the European Medicines Agency [EMA]. This was based on the favorable results ...

(Nasdaq: EXEL) today reported financial results for the third quarter of 2024, provided an update on progress toward achieving key corporate objectives, and detailed its recent and anticipated ...

Austria, Belgium, Czechia, Finland, Northern Ireland, Norway, Poland, Portugal, Republic of Ireland, Scotland, Serbia, Sweden, Ukraine and Wales are into round 2. The ...

Keytruda, a cancer treatment drug, has achieved $25 billion in global sales. Its mechanism boosts the immune system to fight cancer. In India, its high cost limits access. With patents expiring soon, ...

The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market, the drug regulator stated. (Image Credits: Pixabay) The Central Drugs Standard ...

Two local experts share how Dublin and Grosseto are supporting tourism initiatives that encourage exploration of the natural landscapes surrounding their cities. Discover Dublin and Grosseto ...

Copyright 2024 The Associated Press. All Rights Reserved. European Commission President Ursula von der Leyen, left, shakes hands with Serbian President Aleksandar ...

With these approvals, KEYTRUDA is now authorized for 30 indications in the EU, including five in gynecologic cancers, Merck said in a statement. RAHWAY: Merck, also known as MSD outside the US and ...

PARIS :The European Space Agency unveiled plans on Thursday to speed up payments to the space industry in the face of mounting job cuts, while imposing more scrutiny following cost overruns and ...